Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 17949289)

1.

Development and pilot evaluation of novel genetic educational materials designed for an underserved patient population.

Lubitz RJ, Komaromy M, Crawford B, Beattie M, Lee R, Luce J, Ziegler J.

Genet Test. 2007 Fall;11(3):276-90.

PMID:
17949289
2.

Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital.

Lee R, Beattie M, Crawford B, Mak J, Stewart N, Komaromy M, Esserman L, Shaw L, McLennan J, Strachowski L, Luce J, Ziegler J.

Genet Test. 2005 Winter;9(4):306-12.

PMID:
16379544
3.

Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.

Forman AD, Hall MJ.

Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x. Review.

PMID:
19775331
4.

BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.

Pal T, Vadaparampil S, Betts J, Miree C, Li S, Narod SA.

Genet Test. 2008 Sep;12(3):401-7. doi: 10.1089/gte.2007.0108.

PMID:
18752448
5.

Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.

Vadaparampil ST, Quinn GP, Miree CA, Brzosowicz J, Carter B, Laronga C.

Ann Surg Oncol. 2009 Jul;16(7):1973-81. doi: 10.1245/s10434-009-0479-4. Epub 2009 Apr 30.

PMID:
19408048
6.

Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines.

Hall J, Gray S, A'Hern R, Shanley S, Watson M, Kash K, Croyle R, Eeles R.

Fam Cancer. 2009;8(1):5-13. doi: 10.1007/s10689-008-9201-0. Epub 2008 Aug 5.

PMID:
18679829
7.

Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.

Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, Yoon SY, Taib NA, Thong MK, Yip CH, Teo SH.

Breast Cancer Res. 2008;10(4):R59. doi: 10.1186/bcr2118. Epub 2008 Jul 16.

8.

Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.

Loescher LJ, Lim KH, Leitner O, Ray J, D'Souza J, Armstrong CM.

Oncol Nurs Forum. 2009 Mar;36(2):E57-67. doi: 10.1188/09.ONF. E57-E67.

PMID:
19273395
9.

BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer.

Kessler L, Domchek S, Stopfer J, Halbert CH.

Community Genet. 2008;11(4):193-200. doi: 10.1159/000116879. Epub 2008 Apr 14.

PMID:
18417966
10.

Family stories and the use of heuristics: women from suspected hereditary breast and ovarian cancer (HBOC) families.

Kenen R, Ardern-Jones A, Eeles R.

Sociol Health Illn. 2003 Nov;25(7):838-65.

PMID:
19774749
11.

Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.

Peshkin BN, Demarco TA, Graves KD, Brown K, Nusbaum RH, Moglia D, Forman A, Valdimarsdottir H, Schwartz MD.

Genet Test. 2008 Mar;12(1):37-52. doi: 10.1089/gte.2006.0525.

PMID:
18373403
12.

Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients.

Lee E, McKean-Cowdin R, Ma H, Chen Z, Van Den Berg D, Henderson BE, Bernstein L, Ursin G.

Breast Cancer Res. 2008;10(1):R19. doi: 10.1186/bcr1865. Epub 2008 Feb 19.

13.

Hereditary breast and ovarian cancer syndrome : the impact of race on uptake of genetic counseling and testing.

Simon MS, Petrucelli N.

Methods Mol Biol. 2009;471:487-500. doi: 10.1007/978-1-59745-416-2_25.

PMID:
19109796
14.

Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).

Juan AS, Wakefield CE, Kasparian NA, Kirk J, Tyler J, Tucker K.

Genet Test. 2008 Dec;12(4):523-32. doi: 10.1089/gte.2008.0035.

PMID:
19072564
15.

Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.

Kelly KM, Senter L, Leventhal H, Ozakinci G, Porter K.

Patient Educ Couns. 2008 Jan;70(1):135-42. Epub 2007 Nov 7.

PMID:
17988821
16.

Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part I).

Snyder CL, Lynch JF, Lynch HT.

Breast J. 2009 Sep-Oct;15 Suppl 1:S2-10. doi: 10.1111/j.1524-4741.2009.00802.x.

PMID:
19775325
17.

Online patient education and risk assessment: project OPERA from Cancerbackup. Putting inherited breast cancer risk information into context using argumentation theory.

Mackay J, Schulz P, Rubinelli S, Pithers A.

Patient Educ Couns. 2007 Aug;67(3):261-6. Epub 2007 Jun 21. Review.

PMID:
17590305
18.

Practical aspects of delivering hereditary cancer risk counseling.

DeMarco TA, Smith KL, Nusbaum RH, Peshkin BN, Schwartz MD, Isaacs C.

Semin Oncol. 2007 Oct;34(5):369-78. Review.

PMID:
17920890
19.

Moving genetics into clinical cancer care: examples from BRCA gene testing and telemedicine.

Mackay J, Taylor A.

Breast. 2006 Dec;15 Suppl 2:S65-70. Erratum in: Breast. 2008 Apr;17(2):213.

PMID:
17382866
20.

CHESS (Comprehensive Health Enhancement Support System): an interactive computer system for women with breast cancer piloted with an underserved population.

McTavish FM, Gustafson DH, Owens BH, Hawkins RP, Pingree S, Wise M, Taylor JO, Apantaku FM.

J Ambul Care Manage. 1995 Jul;18(3):35-41.

PMID:
10143478
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk